When FDA Oversees Trials Overseas: Foreign Clinical Trial Considerations
October 01, 2026
October 01, 2026
BOSTON, Massachusetts, Oct. 1 [Category: BizLaw/Legal] -- Foley Hoag, a law firm, posted the following news:
* * *
When FDA Oversees Trials Overseas: Foreign Clinical Trial Considerations
*
Conducting clinical trials outside the United States raises significant regulatory concerns that sponsors must evaluate before relying on foreign data to support a marketing approval submission or Investigational New Drug Application (IND) to the United Stat . . .
* * *
When FDA Oversees Trials Overseas: Foreign Clinical Trial Considerations
*
Conducting clinical trials outside the United States raises significant regulatory concerns that sponsors must evaluate before relying on foreign data to support a marketing approval submission or Investigational New Drug Application (IND) to the United Stat . . .